Saved in:
| Main Authors: | Corrado Girmenia, Tiziana Lazzarotto, Massimo Martino, Francesca Bonifazi, Fausto Baldanti, Pierangelo Clerici, Franco Citterio, Luciano De Carlis, Giovanni Barosi, Paolo Antonio Grossi |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2025
|
| Subjects: | |
| Online Access: | https://onlinelibrary.wiley.com/doi/10.1111/ctr.70255 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Resistant/Refractory Cytomegalovirus Retinitis in Solid Organ and Hematopoietic Stem Cell Transplant Recipients: The Cause‐or‐Consequence Dilemma
by: Renato Pascale, et al.
Published: (2026)
by: Renato Pascale, et al.
Published: (2026)
Cytomegalovirus DNA Doubling Time for Early Identification of Clinically Significant Infection Episodes in Allogeneic Hematopoietic Stem Cell Transplant Recipients Undergoing Primary Letermovir Prophylaxis: A Multicenter Study
by: Estela Giménez, et al.
Published: (2025)
by: Estela Giménez, et al.
Published: (2025)
Reduction in Length of Hospital Stays for Allogeneic Hematopoietic Stem‐Cell Transplantation in the Letermovir Era
by: Hiroki Hosoi, et al.
Published: (2025)
by: Hiroki Hosoi, et al.
Published: (2025)
Cytomegalovirus Infection After CD‐34 Selected Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis
by: Brennan Collis, et al.
Published: (2025)
by: Brennan Collis, et al.
Published: (2025)
Molecular Profile and Dynamics of Commensal Viruses in Brazilian Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation
by: Gabriel Montenegro de Campos, et al.
Published: (2025)
by: Gabriel Montenegro de Campos, et al.
Published: (2025)
Varicella‐Zoster Virus Reactivation After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation, Single‐Center Experience of Acyclovir Prophylaxis
by: Galip Arıcı, et al.
Published: (2024)
by: Galip Arıcı, et al.
Published: (2024)
Clinical and Economic Impact of CMV Infection in Allogeneic Hematopoietic Stem Cell Transplantation: Perspectives from a Middle‐Income Nation
by: Gin Gin Gan, et al.
Published: (2024)
by: Gin Gin Gan, et al.
Published: (2024)
Cidofovir Treatment for Prevention of BK Virus‐Associated Hemorrhagic Cystitis in Pediatric Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
by: Bo Lv, et al.
Published: (2025)
by: Bo Lv, et al.
Published: (2025)
Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia With Active Left Neck Tuberculosis: A Case Report
by: Ying He, et al.
Published: (2025)
by: Ying He, et al.
Published: (2025)
Association of CYP2C19 Single Nucleotide Polymorphism With Hemorrhagic Cystitis After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation
by: Weiliang Zhang, et al.
Published: (2026)
by: Weiliang Zhang, et al.
Published: (2026)
Letermovir Conversion for Cytomegalovirus Prophylaxis in Solid Organ Transplant
by: Suneri J. Amin, et al.
Published: (2025)
by: Suneri J. Amin, et al.
Published: (2025)
Similarities and Differences Between Allogeneic Hematopoietic Cell and Organ Transplantation and What We Can Learn From Each Other to Guide Global Health Strategy
by: Hildegard T. Greinix, et al.
Published: (2025)
by: Hildegard T. Greinix, et al.
Published: (2025)
The Changing Epidemiology of Breakthrough Invasive Fungal Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the Era of Modified‐Release Posaconazole Prophylaxis
by: Shio Yen Tio, et al.
Published: (2025)
by: Shio Yen Tio, et al.
Published: (2025)
Clinical and Microbiological Insights Into Invasive Fusariosis Following Allogeneic Hematopoietic Stem Cell Transplantation: A 15‐Year Single‐Center Analysis
by: Jotaro Yamamoto, et al.
Published: (2026)
by: Jotaro Yamamoto, et al.
Published: (2026)
HHV‐8/KSHV in Solid Organ Transplantation: Current Gaps of Knowledge and Future Directions
by: Alessandra Mularoni, et al.
Published: (2026)
by: Alessandra Mularoni, et al.
Published: (2026)
Utility and Safety of Romiplostim in Pediatric Allogeneic Stem Cell Transplantation
by: Srividhya Senthil, et al.
Published: (2025)
by: Srividhya Senthil, et al.
Published: (2025)
Effects of HPgV‐1 Infections on Clinical Outcomes in Patients With Acute Lymphoblastic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: A Matched Case‐Control Study
by: Zhanjia Li, et al.
Published: (2026)
by: Zhanjia Li, et al.
Published: (2026)
The Impact of CYP3A4, CYP3A5, and ABCB1 Polymorphisms on Cyclosporine Concentration in Leukemia Patients After Allogeneic Hematopoietic Stem Cell Transplantation
by: Zahra Salehi, et al.
Published: (2025)
by: Zahra Salehi, et al.
Published: (2025)
Effect of Antibiotics With Anaerobic Coverage on Graft‐Versus‐Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta‐Analysis
by: Hiroshi Ito, et al.
Published: (2025)
by: Hiroshi Ito, et al.
Published: (2025)
Transplantation Related Mortality Did Not Show Significant Differences in Patients Aged Above 55 Years With Hematological Malignancies Receiving Allogeneic Hematopoietic Stem Cell Transplantation in a Real‐World Study
by: Jing Liu, et al.
Published: (2025)
by: Jing Liu, et al.
Published: (2025)
Lung Biopsies in Patients Referred for Allogeneic Hematopoietic Cell Transplantation: Diagnostic Accuracy, Diagnostic Yield, and Clinical Utility
by: Sergio Rodriguez‐Rodriguez, et al.
Published: (2026)
by: Sergio Rodriguez‐Rodriguez, et al.
Published: (2026)
Aspergillus versicolor Meningitis in a Patient With Refractory Acute Myeloid Leukemia After Allogeneic Hematopoietic Cell Transplantation
by: Naonori Harada, et al.
Published: (2025)
by: Naonori Harada, et al.
Published: (2025)
Persisting Gaps in Cytomegalovirus Prevention and Management After Solid Organ Transplantation in a Resource‐Limited Setting
by: Guilherme Santoro‐Lopes, et al.
Published: (2025)
by: Guilherme Santoro‐Lopes, et al.
Published: (2025)
Real‐World Experience With Maribavir for Treatment of Refractory or Resistant Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients and Hematologic Malignancy Patients
by: Marilyne Daher, et al.
Published: (2025)
by: Marilyne Daher, et al.
Published: (2025)
Twice‐Weekly Micafungin as Antifungal Prophylaxis in Children Undergoing Hematopoietic Stem Cell Transplantation
by: Syaza Ab Rahman, et al.
Published: (2026)
by: Syaza Ab Rahman, et al.
Published: (2026)
Long‐Term Endocrine Effects of Hematopoietic Stem Cell Transplantation in Children: A Reappraisal
by: Dilek Gürlek Gökçebay, et al.
Published: (2026)
by: Dilek Gürlek Gökçebay, et al.
Published: (2026)
Long‐Term Outcomes of Hematopoietic Stem Cell Transplantation in Mucopolysaccharidoses Patients Without Radiation
by: Mohammad Jahanpanah, et al.
Published: (2025)
by: Mohammad Jahanpanah, et al.
Published: (2025)
Invasive Fungal Disease in Allogeneic Hematopoietic Cell Transplantation: New Risk Factors and New Therapeutic Options in a Changing World
by: Abby P. Douglas, et al.
Published: (2026)
by: Abby P. Douglas, et al.
Published: (2026)
Cytomegalovirus Post‐Prophylaxis Surveillance in High‐Risk Kidney and Liver Recipients Prevents CMV End‐Organ Disease and Ganciclovir‐Resistance
by: Margaret R. Jorgenson, et al.
Published: (2024)
by: Margaret R. Jorgenson, et al.
Published: (2024)
Acute Appendicitis in Pediatric Hematopoietic Stem Cell Transplant Recipients: A Single‐Center Experience
by: Mustafa Okumuş, et al.
Published: (2026)
by: Mustafa Okumuş, et al.
Published: (2026)
Preventing Cat‐Astrophe: Toxoplasma Seroprevalence and Prophylaxis Adherence After Allogeneic Stem Cell Transplant
by: Manogna Metlapalli, et al.
Published: (2026)
by: Manogna Metlapalli, et al.
Published: (2026)
Donors Infectious Risk Stratification: Activity of the Italian National Transplant Center
by: Elena Graziano, et al.
Published: (2025)
by: Elena Graziano, et al.
Published: (2025)
The First Phylogenetically Confirmed Hemorrhagic Cystitis Outbreak Among Pediatric Hematopoietic Stem Cell Transplant Recipients
by: Tugba Nukte Tezel, et al.
Published: (2025)
by: Tugba Nukte Tezel, et al.
Published: (2025)
Impact of Early Cyclosporine on Cytokine Release Syndrome and Outcomes in Pediatric Haploidentical Hematopoietic Stem Cell Transplantation
by: Veerendra C. Patil, et al.
Published: (2025)
by: Veerendra C. Patil, et al.
Published: (2025)
Severe Food Protein‐Induced Enterocolitis Syndrome After Hematopoietic Stem Cell Transplantation: Pediatric Case Report
by: Laura Alonso García, et al.
Published: (2024)
by: Laura Alonso García, et al.
Published: (2024)
The Eastern Cooperative Oncology Group Score Rather Than Donor Type Impacts Clinical Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Severe Aplastic Anemia Patients Aged 51–60 Years: A Retrospective Study From the Chinese Blood and Marrow Transplant Registry
by: Xin Zhao, et al.
Published: (2025)
by: Xin Zhao, et al.
Published: (2025)
Real‐World Off‐Label Use of Letermovir Prophylaxis for Cytomegalovirus Prevention in Non‐Kidney Solid Organ Transplant Recipients: Outcomes, Safety, and Review of Literature
by: Abdallah Mughrabi, et al.
Published: (2026)
by: Abdallah Mughrabi, et al.
Published: (2026)
Clinically Significant EBV Infection in Allogeneic Stem Cell Transplanted Children Receiving Letermovir as Primary CMV Prophylaxis
by: Christina Oikonomopoulou, et al.
Published: (2025)
by: Christina Oikonomopoulou, et al.
Published: (2025)
The Pretransplant EASIX Score Predicts Transplant‐Related Mortality in Children Undergoing Hematopoietic Stem Cell Transplantation for Non‐Malignant Disorders
by: Vedat Uygun, et al.
Published: (2026)
by: Vedat Uygun, et al.
Published: (2026)
Case Report: Hematopoietic Stem Cell Transplantation to Treat Severe Acquired Aplastic Anemia in a Pediatric Kidney Transplant Recipient
by: Gintarė Mierkienė, et al.
Published: (2025)
by: Gintarė Mierkienė, et al.
Published: (2025)
Similar Items
-
Resistant/Refractory Cytomegalovirus Retinitis in Solid Organ and Hematopoietic Stem Cell Transplant Recipients: The Cause‐or‐Consequence Dilemma
by: Renato Pascale, et al.
Published: (2026) -
Cytomegalovirus DNA Doubling Time for Early Identification of Clinically Significant Infection Episodes in Allogeneic Hematopoietic Stem Cell Transplant Recipients Undergoing Primary Letermovir Prophylaxis: A Multicenter Study
by: Estela Giménez, et al.
Published: (2025) -
Reduction in Length of Hospital Stays for Allogeneic Hematopoietic Stem‐Cell Transplantation in the Letermovir Era
by: Hiroki Hosoi, et al.
Published: (2025) -
Cytomegalovirus Infection After CD‐34 Selected Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis
by: Brennan Collis, et al.
Published: (2025) -
Molecular Profile and Dynamics of Commensal Viruses in Brazilian Patients Who Underwent Allogeneic Hematopoietic Stem Cell Transplantation
by: Gabriel Montenegro de Campos, et al.
Published: (2025)